To the full analysis
Buyback calculator for AnaptysBio
AnaptysBio stock: key metrics
ANABAnaptysBio had an operating margin of 20.4% and a return on invested capital (ROIC) of 9.9% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | −60.9% | −96.4% | −101.1% |
| 2014 | 45.6% | 30.7% | 1.5% |
| 2015 | 1.5% | −18.9% | −30.8% |
| 2016 | 7.6% | −18.1% | −25.5% |
| 2017 | −194.4% | −287.8% | −300.7% |
| 2018 | −1,023.9% | −1,334.4% | −1,233.1% |
| 2019 | −1,141.7% | −1,342.9% | −1,216.7% |
| 2020 | −6.7% | −31.8% | −26.6% |
| 2021 | −55.9% | −89.9% | −91.5% |
| 2022 | −763.2% | −1,119.4% | −1,251.3% |
| 2023 | −671.0% | −958.3% | −953.7% |
| 2024 | −79.5% | −125.9% | −159.1% |
| 2025 | 99.0% | 20.4% | −5.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | −100.0% | no data | −100.0% |
| 2014 | 3.9% | 65.1% | 0.9% |
| 2015 | −12.8% | −8.4% | −9.6% |
| 2016 | −10.8% | −4.5% | −6.8% |
| 2017 | −9.8% | −60.3% | −9.1% |
| 2018 | −12.7% | −74.7% | −12.1% |
| 2019 | −24.0% | −18.8% | −22.4% |
| 2020 | −5.0% | −4.7% | −4.8% |
| 2021 | −16.2% | −8.8% | −9.0% |
| 2022 | −49.1% | −15.0% | −21.1% |
| 2023 | −100.0% | −26.0% | −36.2% |
| 2024 | −100.0% | −21.2% | −30.0% |
| 2025 | −35.6% | 9.9% | −3.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.